Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers
- PMID: 21422863
- PMCID: PMC3084323
- DOI: 10.1097/AOG.0b013e3182110ea3
Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers
Abstract
Objective: To investigate the association of body mass index (BMI) in early adulthood and endometrial cancer risk for carriers of a germline mutation in a DNA mismatch repair gene.
Methods: We estimated the association between BMI at age 18-20 years and endometrial cancer risk for mismatch repair gene mutation carriers and, as a comparison group, noncarriers using 601 female carriers of a germline mutation in a mismatch repair gene (245 MLH1, 299 MSH2, 38 MSH6, and 19 PMS2) and 533 female noncarriers from the Colon Cancer Family Registry using a weighted Cox proportional hazards regression.
Results: During 51,693 person-years of observation, we observed diagnoses of endometrial cancer for 126 carriers and eight noncarriers. For carriers, there was no evidence of an association between BMI at age 20 years and endometrial cancer (adjusted hazard ratio 0.73 per 5 kg/m²; 95% confidence interval [CI], 0.40-1.34; P=.31). For noncarriers, endometrial cancer risk increased by 74% for each 5-kg/m² increment in BMI (adjusted hazard ratio 1.74; 95% CI 1.27-2.37; P<.001). The hazard ratio for BMI and endometrial cancer for noncarriers was greater than for carriers (P=.04).
Conclusion: The effect of body mass on endometrial cancer risk depends on the woman's mismatch repair gene mutation carrier status, suggesting obesity-independent endometrial carcinogenesis for carriers.
Level of evidence: II.
Conflict of interest statement
Similar articles
-
Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes.Br J Cancer. 2011 Jun 28;105(1):162-9. doi: 10.1038/bjc.2011.172. Epub 2011 May 10. Br J Cancer. 2011. PMID: 21559014 Free PMC article.
-
Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.J Clin Oncol. 2014 Jan 10;32(2):90-100. doi: 10.1200/JCO.2013.51.2129. Epub 2013 Dec 9. J Clin Oncol. 2014. PMID: 24323032 Free PMC article.
-
Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study.J Clin Oncol. 2012 Mar 20;30(9):958-64. doi: 10.1200/JCO.2011.39.5590. Epub 2012 Feb 13. J Clin Oncol. 2012. PMID: 22331944 Free PMC article.
-
PMS2 monoallelic mutation carriers: the known unknown.Genet Med. 2016 Jan;18(1):13-9. doi: 10.1038/gim.2015.27. Epub 2015 Apr 9. Genet Med. 2016. PMID: 25856668 Free PMC article. Review.
-
Phenotype associated with recessively inherited mutations in DNA mismatch repair (MMR) genes.Biochem Soc Trans. 2005 Aug;33(Pt 4):718-20. doi: 10.1042/BST0330718. Biochem Soc Trans. 2005. PMID: 16042583 Review.
Cited by
-
Cancer risks for MLH1 and MSH2 mutation carriers.Hum Mutat. 2013 Mar;34(3):490-7. doi: 10.1002/humu.22262. Hum Mutat. 2013. PMID: 23255516 Free PMC article.
-
An effective algorithm to detect the possibility of being MSI phenotype in endometrial cancer given the BMI status and histological subtype: a statistical study.Clin Transl Oncol. 2022 Sep;24(9):1809-1817. doi: 10.1007/s12094-022-02837-4. Epub 2022 May 5. Clin Transl Oncol. 2022. PMID: 35511397 Free PMC article.
-
The genetic basis of Lynch syndrome and its implications for clinical practice and risk management.Appl Clin Genet. 2014 Jul 22;7:147-58. doi: 10.2147/TACG.S51483. eCollection 2014. Appl Clin Genet. 2014. PMID: 25161364 Free PMC article. Review.
-
Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.J Natl Cancer Inst. 2015 Jun 24;107(9):djv170. doi: 10.1093/jnci/djv170. Print 2015 Sep. J Natl Cancer Inst. 2015. PMID: 26109217 Free PMC article.
-
Energy balance related lifestyle factors and risk of endometrial and colorectal cancer among individuals with lynch syndrome: a systematic review.Fam Cancer. 2019 Oct;18(4):399-420. doi: 10.1007/s10689-019-00135-7. Epub 2019 Jun 24. Fam Cancer. 2019. PMID: 31236808 Free PMC article.
References
-
- Vasen HFA, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology. 1999;116(6):1453–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 CA074799-03/CA/NCI NIH HHS/United States
- U01 CA074799/CA/NCI NIH HHS/United States
- U01 CA074806-09S2/CA/NCI NIH HHS/United States
- U01 CA074783-06/CA/NCI NIH HHS/United States
- U01 CA074794-10/CA/NCI NIH HHS/United States
- U01 CA074799-07/CA/NCI NIH HHS/United States
- U01 CA074800-09S1/CA/NCI NIH HHS/United States
- U01 CA074800-06/CA/NCI NIH HHS/United States
- U01 CA074783-09/CA/NCI NIH HHS/United States
- U01 CA097735-05S1/CA/NCI NIH HHS/United States
- U01 CA074799-04S1/CA/NCI NIH HHS/United States
- U01 CA074806-05/CA/NCI NIH HHS/United States
- U01 CA074799-03S1/CA/NCI NIH HHS/United States
- U01 CA097735-05/CA/NCI NIH HHS/United States
- U01 CA074800-05/CA/NCI NIH HHS/United States
- U24 CA074783/CA/NCI NIH HHS/United States
- U01 CA074800-04/CA/NCI NIH HHS/United States
- U01 CA074800-04S3/CA/NCI NIH HHS/United States
- U01 CA074783-04S1/CA/NCI NIH HHS/United States
- U01 CA074783-03/CA/NCI NIH HHS/United States
- U01 CA074799-09S2/CA/NCI NIH HHS/United States
- U01 CA074800-09/CA/NCI NIH HHS/United States
- U01 CA074799-06/CA/NCI NIH HHS/United States
- U01 CA074783-05/CA/NCI NIH HHS/United States
- U24 CA074794/CA/NCI NIH HHS/United States
- U01 CA074794-10S1/CA/NCI NIH HHS/United States
- U01 CA074806-09S1/CA/NCI NIH HHS/United States
- U01 CA097735-04/CA/NCI NIH HHS/United States
- U24 CA074806/CA/NCI NIH HHS/United States
- U01 CA074800-03S2/CA/NCI NIH HHS/United States
- U24 CA097735/CA/NCI NIH HHS/United States
- U01 CA074799-04S2/CA/NCI NIH HHS/United States
- U01 CA074794/CA/NCI NIH HHS/United States
- U01 CA074783-09S2/CA/NCI NIH HHS/United States
- U01 CA074806-03/CA/NCI NIH HHS/United States
- U01 CA074806-04S1/CA/NCI NIH HHS/United States
- U01 CA074799-09/CA/NCI NIH HHS/United States
- U01 CA074800-07/CA/NCI NIH HHS/United States
- U01 CA074799-09S1/CA/NCI NIH HHS/United States
- U01 CA074783-08/CA/NCI NIH HHS/United States
- U01 CA074783-04S2/CA/NCI NIH HHS/United States
- U01 CA097735-03/CA/NCI NIH HHS/United States
- U01 CA074783-04/CA/NCI NIH HHS/United States
- U01 CA074783-07/CA/NCI NIH HHS/United States
- U01 CA074800-03/CA/NCI NIH HHS/United States
- U01 CA074800-04S2/CA/NCI NIH HHS/United States
- U01 CA097735/CA/NCI NIH HHS/United States
- U01 CA074806-09/CA/NCI NIH HHS/United States
- U01 CA074806-06/CA/NCI NIH HHS/United States
- U01 CA074800-08/CA/NCI NIH HHS/United States
- U01 CA074799-08/CA/NCI NIH HHS/United States
- U01 CA074800-04S1/CA/NCI NIH HHS/United States
- CA-95-011/CA/NCI NIH HHS/United States
- U01 CA074783/CA/NCI NIH HHS/United States
- U01 CA074799-04/CA/NCI NIH HHS/United States
- U01 CA074806-07/CA/NCI NIH HHS/United States
- U01 CA097735-02/CA/NCI NIH HHS/United States
- U01 CA074806-04S2/CA/NCI NIH HHS/United States
- U01 CA074806-08/CA/NCI NIH HHS/United States
- U24 CA074799/CA/NCI NIH HHS/United States
- U01 CA074806/CA/NCI NIH HHS/United States
- U24 CA074800/CA/NCI NIH HHS/United States
- U01 CA074783-09S1/CA/NCI NIH HHS/United States
- U01 CA074799-05/CA/NCI NIH HHS/United States
- U01 CA097735-01/CA/NCI NIH HHS/United States
- U01 CA074806-04/CA/NCI NIH HHS/United States
- U01 CA074800/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous